The New Times on MSN5h
Akagera Medicines’ TB drug shows ‘promising’ results in preclinical trials
Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical trials of an antibiotic drug for the treatment of pulmonary tuberculosis (TB).
BlackDoctor.org10h
A Black Researcher Is Testing A Late-Stage Tuberculosis Vaccine
TB cases rise globally. New vaccine trials offer hope. Learn about TB's impact, risks, and a Dr. Alemnew Dagnew's fight for a ...
Science News14h
A new antifungal drug works in a surprising way
Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.
Open Access Government15h
University of Oxford launches first human aerosol TB vaccine trial
The University of Oxford has commenced a new clinical trial called TB-45, which will test tuberculosis (TB) vaccine safety ...